De Jesus-Acosta A, et al. Invest. N. Drugs (2014) cited as Ref 586 in DOI: 10.1038/s41392-020-0110-5
Revision as of 15:10, 20 May 2020 by Maintenance script (talk | contribs)
Bibliography entry in "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8; DOI: https://doi.org/10.1038/s41392-020-0110-5
| Title | A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma |
|---|---|
| DOI | 10.1007/s10637-014-0083-8 |
| 1st AU | De Jesus-Acosta A |
| PubDate | 2014 |
| Journal | Invest. N. Drugs |
| Volume | 32 |
| Page(s) | 739-745 |
| Cited In | Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5) |